News

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added ...
Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.
The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in June, moving ...
FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.
Carney claimed he had only cash and real estate holdings, and it turns out he held hundreds of stocks, stock options and ...
Founders Development Company Announces New 351 Unit Multifamily Development RailRoad Lofts in Texas ...
It’s easy to get caught up in a rally, especially when the S&P 500 keeps pushing and tech stocks feel revitalized. However, in a bull run, there are always weak links. 💵💰Don't miss the move: ...
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
The artist is revisiting his roots and making special memories with his and Ricky Martin's twins Lucía and Renn ...
Agenus (AGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agenus (AGEN) is a stock that can certainly grab the attention ...